Published by Josh White on 24th November 2025
(Sharecast News) - Bayer reported a major boost to its drug pipeline on Monday morning, after its experimental anticoagulant asundexian delivered positive results in a large phase three trial, easing concerns following a setback last year and lifting investor sentiment.
URL: http://www.digitallook.com/dl/news/story/35516314/...